Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Are FDA And CMS Growing Apart? AEI’s Gottlieb Thinks So

Executive Summary

While many pharmaceutical industry observers like to talk about the new ways in which FDA and CMS are working together and sharing information, Scott Gottlieb is offering a contrarian view on relations between the two agencies
Advertisement

Related Content

Heads Of FDA, CMS And Other HHS Agencies May Be Named Within A Few Weeks
Baucus Wants To Keep Comparative Effectiveness Separate From Cost Control
Hypertensives May Get Class Outcome Labels; Industry Wary Of Broad Efficacy
CMS May Take Studious Approach To Covering ESAs In Cancer Setting
FDA Warning Letter Cites Cephalon For Broadening Provigil Indications
CMS Splits Coverage With Evidence Development Into Two Categories
CMS Splits Coverage With Evidence Development Into Two Categories
Advertisement
UsernamePublicRestriction

Register

PS050381

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel